Picrorhiza kurroa is a recognized herb in the Ayurvedic and Chinese system of traditional medicine. It is effective in treating a variety of diseases ranging from digestion problems to paralysis. Thus it is essential to rule out any kind of toxicity, mutagenicity or carcinogenicity in the plant to be used as a medicine. The study was conducted to evaluate ability of Picrorhiza kurroa to induce reverse mutations at the histidine locus in several strains of Salmonella typhimurium in the absence or presence of exogenous metabolic activation system (S9) containing microsomal enzymes. The bacterial reverse mutation assay has been shown to be a sensitive, rapid and accurate indicator of mutagenic activity of a wide range of chemical classes. All bacterial strains showed negative responses over the entire dose range. No significant dose related increase was observed in the number of revertants in the two independent experiments. Based on the results
Introduction
Picrorhiza kurroa Royle ex. Benth (Family Scrophularaceae) commonly called Kutki or Kutka is a recognized herb in the Ayurvedic and Chinese system of traditional medicine. It is a wonder herb with hepatoprotective, [1] [2] [3] [4] anticholestatic, [5] antioxidant, [6] antidiabetic, [7] and immune-modulating properties. [8] [9] [10] The leaves, root and rhizome of Picrorhiza are used to treat liver and upper respiratory tract disorders, chronic diarrhea, and scorpion sting. It is also effective in treating a variety of diseases ranging from digestion problems to malaria, jaundice, allergy, epilepsy, paralysis, rheumatoid arthritis and skin diseases [11] [12] [13] [14] . Picrorhiza extract may be of therapeutic value in treating viral hepatitis as it has promising anti-hepatitis B surface antigen activity [15] . In rats infected with malaria, Picrorhiza restored depleted glutathione levels, thereby enhancing detoxification and antioxidation, and helping maintain a normal oxidationreduction balance. [16] Nowadays therapeutic importance of plants is well recognized in both Western and Eastern medicinal systems. However, some of them are potentially toxic, mutagenic or carcinogenic thus their toxicity profiling is essential for their use as medicine. We had earlier evaluated the ability of liposome-encapsulated Picrorhiza kurroa extract [17] to induce reverse mutations at the histidine locus in several strains of Salmonella typhimurium in the absence /presence of exogenous metabolic activation system. The liposome-encapsulated Picrorhiza kurroa extract was found to be non-mutagenic in the reverse mutation assay. The bacterial reverse mutation assay has been shown to be a sensitive, rapid and accurate indicator of mutagenic activity of a wide range of chemical classes.
In continuation of our work in this article we compared the mutagenic potential of Picrorhiza kurroa extract with liposome-encapsulated extract.
Material and Methods

Material & Extraction
Picrorhiza kurroa rhizomes were gifted by Patanjali Ayurved Ltd., Haridwar, India and stored in ambient conditions for further study. The sample specimen is
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deposited at Patanjali Research Foundation, Haridwar, India. The other solvents and chemicals were purchase from Sigma-Aldrich, India. Salmonella typhimurium tester strains (TA1537, TA1535, TA98, TA100 and TA102) were received from Molecular Toxicology, Inc. USA. Other chemicals were purchased from SigmaAldrich, India. The powdered Picrorhiza kurroa rhizomes were subjected to extraction using Methanol: Water (60:40). The extract was evaporated to dryness in a rotary flash evaporator at a temperature not exceeding 60°C, and then stored in air tight container.
Methods
The bacterial reverse mutation test (Ames test) was performed with Salmonella typhimurium strains TA1537, TA1535, TA98, TA100 and TA102 with/without metabolic activation as described.
[18]
Dose Range finding Study
In the dose range finding study the Picrorhiza kurroa rhizome extract was tested at the dose levels of 78.13, 156.25, 312.5, 625, 1250, 2500 and 5000 µg/ml in the presence (10% S9 mix) and absence of metabolic activation system. The dose range finding study was performed at the above mentioned dose levels in TA98 and TA100 using plate incorporation method. The dose concentration for the main mutagenicity study was determined based on the results of solubility, precipitation and cytotoxicity test.
Precipitation Test
Precipitation test was carried out in all the phases of the study (Cytotoxicity and Mutagenicity test). During precipitation test the bacterial cultures were treated with various test concentrations of the extract in presence and absence of metabolic activation. At the end of treatment, mixture was poured on to minimal glucose agar plates (MGA) and observed for presence or absence of precipitates of test item on MGA plates.
Mutagenicity Assay
Based on data on number of revertant colonies observed during dose range finding study was also considered for main mutagenicity study. The assay was performed using TA1535, TA1537, and TA102 in the presence (10% S9 mix) and absence of S9 mix. Tester strains were exposed to the extract via the plate incorporation methodology at dose levels of 312.5, 625, 1250, 2500 and 5000 µg/ml with and without metabolic activation system.
Plating Procedures
The Salmonella typhimurium tester strains TA1537, TA1535, TA 98, TA 100 and TA102 were labeled with dose groups (A-E) and date of treatment respectively on minimal glucose agar plates at the time of treatment. The plates were labeled as "+S9" and "-S9" for the presence and absence of metabolic activation respectively.
All the treated plates were incubated for 48 to 72 hours at 37 o C ± 2 o C in Biological Oxygen Demand (BOD) incubator in inverted position. At the end of incubation, the condition of the bacterial background lawn was evaluated for evidence of cytotoxicity and presence/absence of precipitation of test item. Evidence of cytotoxicity was scored relative to the vehicle control and recorded along with the revertant counts of that dose group.
Result and Discussion
Strains of Salmonella typhimurium used in this assay are histidine auxotrophs by virtue of conditionally lethal mutations in the histidine operon. When the histidine (his-) dependent cells are exposed to the Picrorhiza kurroa rhizome extract and grown under selective conditions (minimal media with trace amount of histidine and biotin) only those cells which revert to (his+) independence are able to form colonies ( Table 1 ). The trace amount of histidine in the media allows all the plated bacteria to undergo a few cell divisions, which is essential for mutagenesis to be fully expressed. The his+ revertants are readily discernable as colonies against the limited background growth of the his-cells. By using several different tester strains, base pair substitution mutations and frame shift mutations can be detected. Spontaneous reversions occur with each of the strain, which will be considered as background level. Mutagenic compounds cause an increase in the number of revertant colonies relative to the background level.
Dose Range Finding Study
The Picrorhiza kurroa rhizome extract was tested at the dose levels of 78.13, 156.25, 312.5, 625, 1250, 2500 and 5000 µg/ml in the presence (10 % S9 mix) and absence of metabolic activation system in the tester strains TA98 and TA100 ( Table 2) .
Precipitation
Precipitation of the extract on the plate was not observed at the start or at the end of the incubation period ( Table 3) .
Toxicity
To determine the toxicity of test item on the reduction of the bacterial background lawn, the increase in the size of the micro colonies and the reduction of the revertant colonies were examined. The tester strains TA98 and TA100 at the concentration range of 78.13 -5000 µg/plate treated with the extract in the absence and presence of metabolic activation revealed no background bacterial lawn inhibition when compared to vehicle control groups. No reduction of the bacterial background lawn and no decrease in the number of revertants were observed over the concentration range of 78.13 to 5000 µg/plate ( Table 4) .
Mutagenicity
In the dose range finding test, no increase in the number of revertants was observed upon treatment with Picrorhiza kurroa rhizome extract under all conditions tested.
Main Mutagenicity Assay
Based on the data on number of revertant colonies observed during dose range finding study was considered for main mutagenicity study. The main mutagenicity assay was performed with the strains TA1537, TA1535, and TA102 in the presence (10% S9 mix) and absence of metabolic activation ( Table 5 ).
Precipitation
Precipitation of Picrorhiza kurroa rhizome extract on the plate was not observed at the start or at the end of the incubation period.
Toxicity
No reduction of the bacterial background lawn and no biologically relevant decrease in the number of revertants were observed in all strains at any concentration tested in the absence and presence of metabolic activation.
Mutagenicity
In the main mutagenicity assay, no increase in the number of revertants was observed upon treatment with Picrorhiza kurroa rhizome extract under all conditions tested ( Table 6) . Similar results were obtained for liposome-encapsulated extract. [17] 
Conclusion
All bacterial strains (TA1537, TA1535, TA98, TA100 and TA102) showed negative responses over the entire dose range, i.e. no significant dose related increase was observed in the number of revertants in the two independent experiments. The negative and strain-specific positive control values were within the normal acceptable ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly. The results obtained were similar those observed in the previous study with liposome-encapsulated extract. Based on the results of the study it can be concluded that Picrorhiza kurroa rhizome extract in either case is not mutagenic in the Salmonella typhimurium reverse mutation assay. However, detailed in vivo studies are required to confirm its toxicity.
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